Moreover, the malignancy-associated and non-malignancy-associated SLE groups did not differ in antithrombin activity, protein C activity, the free protein S level, factor VIII activity, factor V Leiden gene mutations, and G20210A prothrombin gene mutations (data not shown). This evidence concerns the gene F5 and systemic lupus erythematosus.